Bull Horn Holdings Corp. (NASDAQ:BHSE) disclosed this afternoon that its shareholders have approved its combination with biopharmaceutical company Coeptis (OTC:COEP) in a special meeting held earlier today.
A total of 2,869,654 ordinary shares, or approximately 88.5% of Bull Horn’s outstanding public shares, were redeemed at today’s meeting. But, the SPAC had already faced previous redemptions of 4,258,586 public shares during a shareholder vote for a timeline extension back in April. This brings the total amount redeemed to 95.04% following today’s completion vote. As a result, BHSE will have approximately 371,760 public shares and $3.8 million remaining in its trust account following the redemptions.
Despite the high amount of redemptions, Bull Horn still expects the deal to be completed promptly following the satisfaction or waiver of the other conditions to the consummation of the business combination. The combined company is expected to trade under the symbol “COEP” once the deal is completed.
The parties initially announced their business combination on April 19. Wexford, Pennsylvania-based Coeptis is developing a pair of therapies designed to improve the efficacy of cancer treatments.
ADVISORS
- Bridgeway Capital Partners served as financial advisors to Coeptis.
- Meister Seelig & Fein LLP served as legal advisors to Coeptis.
- Jones Trading served as financial advisor to Bull Horn.
- Ellenoff Grossman & Schole LLP served as legal advisors to Bull Horn.
McKinley Acquisition Corporation (NASDAQ:MKLYU) has filed for a $150 million SPAC to hunt for an innovative target company with an experienced financial team that has dabbled in SPACs before. The new SPAC is offering investors one right to a 1/10 share in each unit with no overfunding of the trust, but it could provide a...
At the SPAC of Dawn The rain of SPACs has continued with four expected to make their debuts during today’s trading sessions after pricing their IPOs overnight. The largest of these, EQV Ventures II (NASDAQ:EVACU), even managed an upsize, making it the largest SPAC IPO since Ares II (NYSE:AACT) pulled together $450 million in 2023....
EQV Ventures II (NASDAQ:EVACU) announced the pricing of its upsized $420 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “EVACU”, Wednesday, July 2, 2025. The new SPAC plans to merge with an energy target involved in upstream exploration or production. EQV II’s management team is led by...
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....